Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Lowes

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Coronary Artery Disease|February 1, 1994
Low-dose inotropic therapy for ambulatory heart failureM R Bristow, B D Lowes
The Annals of Pharmacotherapy|January 12, 2000
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilolJ Lindenfeld, B D Lowes, M R Bristow
The American Journal of Cardiology|September 25, 1999
Prevalence of depression in congestive heart failureE P Havranek, M G Ware, B D Lowes
Journal of the American College of Cardiology|December 12, 2001
Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockersJ Lindenfeld, A D Robertson, B D Lowes, et al.
Clinical Cardiology|February 7, 2001
Inotropes in the beta-blocker eraB D Lowes, M A Simon, T O Tsvetkova, et al.
Journal of Cardiac Failure|October 18, 2001
Inotropes and beta-blockers: is there a need for new guidelines?M R Bristow, S F Shakar, J V Linseman, et al.
Journal of Cardiac Failure|July 25, 2000
Beta-blockade in adriamycin-induced cardiomyopathyA Noori, J Lindenfeld, E Wolfel, et al.
International Journal of Cardiology|December 18, 2001
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilolB D Lowes, T Tsvetkova, E J Eichhorn, et al.
Clinical Cardiology|December 16, 1998
The role of third-generation beta-blocking agents in chronic heart failureM R Bristow, R L Roden, B D Lowes, et al.
Journal of Cardiac Failure|July 15, 1999
Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failureE P Havranek, K M McGovern, J Weinberger, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Coronary Artery Disease|February 1, 1994
Low-dose inotropic therapy for ambulatory heart failureM R Bristow, B D Lowes
The Annals of Pharmacotherapy|January 12, 2000
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilolJ Lindenfeld, B D Lowes, M R Bristow
The American Journal of Cardiology|September 25, 1999
Prevalence of depression in congestive heart failureE P Havranek, M G Ware, B D Lowes
Journal of the American College of Cardiology|December 12, 2001
Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockersJ Lindenfeld, A D Robertson, B D Lowes, et al.
Clinical Cardiology|February 7, 2001
Inotropes in the beta-blocker eraB D Lowes, M A Simon, T O Tsvetkova, et al.
Journal of Cardiac Failure|October 18, 2001
Inotropes and beta-blockers: is there a need for new guidelines?M R Bristow, S F Shakar, J V Linseman, et al.
Journal of Cardiac Failure|July 25, 2000
Beta-blockade in adriamycin-induced cardiomyopathyA Noori, J Lindenfeld, E Wolfel, et al.
International Journal of Cardiology|December 18, 2001
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilolB D Lowes, T Tsvetkova, E J Eichhorn, et al.
Clinical Cardiology|December 16, 1998
The role of third-generation beta-blocking agents in chronic heart failureM R Bristow, R L Roden, B D Lowes, et al.
Journal of Cardiac Failure|July 15, 1999
Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failureE P Havranek, K M McGovern, J Weinberger, et al.
Pageof 3